August 2012 FDA Recall Atorvastatin Calcium by Ranbaxy Inc.
D-060-2013 - Adulterated Presence of Foreign Tablets

This Class II drug recall was voluntarily initiated by Ranbaxy Inc. on August 21, 2012 for the product Atorvastatin Calcium. The FDA reported the reason for recall as adulterated presence of foreign tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-060-2013

Reason for Recall
Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.
Initiated
08-21-2012
Reported
11-28-2012
Quantity
32,208 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90

Batch or Lot Expiration Information

Lot# : 2407258, Exp 05/14